Purpose To evaluate the immunogenicity of COVID-19 vaccines in patients with diabetes
mellitus (DM) through a systematic approach. Method A comprehensive search was …

Designing and producing an effective vaccine is the best possible way to reduce the burden
and spread of a disease. During the coronavirus disease 2019 (COVID-19) pandemic, many …

As the new year of 2020 approaches, an acute respiratory disease quietly caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus …

Introduction The global spread of COVID-19 has prompted the development of vaccines. A
recombinant adenovirus type-5 vectored COVID-19 vaccine (Ad5-nCoV) developed by …

Objectives The objective of this study is to estimate the effectiveness of COVID-19 vaccines
in people treated within the social security system whose vaccination status was reported to …

We aimed at evaluating quantitative IgG response to BNT162b2 COVID-19 vaccine among
health care workers (HCW), and exploring the role of demographic, clinical, and …

Abstract Background Beginning in March 2021, Mexico vaccinated childcare workers with a
single-dose CanSino Biologics (Adv5-nCoV) coronavirus disease 2019 (COVID-19) …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused the largest
pandemic of this century, and all aspects of this virus are being studied. The efforts to …

Vaccination against the SARS‐Cov‐2 virus is an effective way to protect against the disease
and the severe course of COVID‐19. Forty‐nine fully vaccinated with mRNA vaccines …

After about 2 years since the first detection of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infections in Wuhan, China, in December 2019 that resulted in a worldwide …